Navigation Links
Phase 3 Open-Label Study Comparing Tapentadol Extended Release Tablets to Oxycodone Controlled Release Tablets Published by Pain Practice
Date:7/19/2010

) and headache (tapentadol ER, 13.3; oxycodone CR, 7.6). In the tapentadol ER and oxycodone CR groups, respectively, TEAEs led to discontinuation in 22.1 percent and 36.8 percent of patients.

Chronic pain, affecting an estimated 100 million Americans, continues to be a significant medical challenge in the United States. Osteoarthritis pain and low back pain are particularly prevalent – osteoarthritis pain affects 27 million Americans, and chronic low back pain is the most common cause of disability in developed countries.

Although currently available long-acting opioid analgesics have been shown to provide relief for moderate to severe chronic pain, many are associated with high incidences of side effects, which can cause patients to discontinue their treatment. Research also shows that physicians are uncomfortable prescribing opioids due to these opioid-related side effects.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) and Grunenthal GmbH, conducted this study, which J&JPRD has included as part of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tapentadol ER tablets for the management of moderate to severe chronic pain in patients 18 years of age or older. The FDA currently is reviewing this application and, if approved, PriCara®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., will market tapentadol ER in the United States.

The full article in Pain Practice can be accessed online at http://www3.interscience.wil
'/>"/>

SOURCE PriCara
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... -- UBM Medica US today announced the launch of ... information resource for neurologists and other healthcare providers to ... neurological disorders . The prevalence of ... access to dedicated information for healthcare providers who treat ... , 1 in 6 people are affected ...
(Date:7/23/2014)... , July 23, 2014 Research ... "Diagnostic Electrocardiograph (ECG) Market by Product, End-user & by ... to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... is segmented into three major segments, namely, holter monitor, ... market was valued at $3,683 million in 2013 and ...
(Date:7/23/2014)... 23, 2014 /PRNewswire-iReach/ -- The Centers for Medicare & ... Innovation Network-Quality Improvement Organization (QIN-QIO) contract to a partnership ... Effective August 1, WVMI will launch Quality Insights ... , Pennsylvania , Delaware ... Louisiana.  The Network will engage providers and the community ...
Breaking Medicine Technology:UBM Medica US Launches NeurologyTimes.com 2UBM Medica US Launches NeurologyTimes.com 3Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020 2Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020 3Announcing a New Regional Approach to Medicare Quality Improvement 2
... 20, 2012   Sysmex America, Inc., a global leader ... today announced its 200th placement of Sysmex WAM ... Laboratory.  Sysmex WAM is now connecting nearly 600 sites ... U.S. and Canada. Sysmex WAM plays a key role ...
... Assured Pharmacy (Pinksheets: APHY), a leading specialty pharmacy group ... present at Anda,s 2012 Supply Chain Symposium on Thursday, ... in Palm Beach Gardens, Florida.  Assured Pharmacy has been ... dispensing controlled substances at pharmacies.   Anda ...
Cached Medicine Technology:Sysmex America Achieves Clinical Laboratory Connectivity Milestone 2Assured Pharmacy to Present at Anda's 2012 Supply Chain Symposium 2Assured Pharmacy to Present at Anda's 2012 Supply Chain Symposium 3
(Date:7/23/2014)... The National Quality Forum’s (NQF) Board ... for a defined period that will assess the ... measures for sociodemographic factors, prior to making a ... can be socioeconomic, e.g., income, education, and occupation, ... Growing evidence shows that sociodemographic factors may ...
(Date:7/23/2014)... Recently, iFitDress.com, a professional company of women’s dresses and related ... party dresses . Aside from that, it has launched a ... to 63% off. , “We are excited to offer our ... all manufactured by trustworthy and experienced workers in the fashion ... is great to provide such a great opportunity for our ...
(Date:7/23/2014)... of Exeter has developed a simple, cheap and ... lung disease which attacks immune deficient individuals such ... , The lateral-flow device (LFD), created by Professor ... difficult to diagnose disease caused by the fungus ... aspergillosis is a leading cause of death in ...
(Date:7/23/2014)... July 23, 2014 A new study ... power morcellator ( http://www.injurybeacon.com/power-morcellator/ ) during minimally invasive ... throughout a woman’s body, Bernstein Liebhard LLP reports. The ... Journal of the American Medical Association, looked at 36,000 ... at 500 U.S. hospitals from 2006 to 2012. Ninety-nine ...
(Date:7/23/2014)... (NEW YORK, NY, July 24, 2014) If past ... New York State are about to get a lot ... Massachusetts, laws already on the books allowing NPs to ... contributions to patient care and better relationships with physicians ... to a study from Columbia University School of Nursing, ...
Breaking Medicine News(10 mins):Health News:NQF Board Approves Trial Period to Test Impact of Risk Adjustment of Performance Measures for Sociodemographic Factors 2Health News:Cheap 2014 Vintage Party Dresses From Professional Supplier iFitDress.com 2Health News:New device detects deadly lung disease 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 4Health News:New York law offers nurses more recognition, responsibility 2
... Henrico Doctors, Hospital is a full service acute care ... St. Mary,s Hospital. Early in 2008, Henrico,s administration noted ... St. Mary,s volume was increasing. After investigation, the problem ... and was compounding throughout the facility. Most notably, ...
... PORTLAND, Ore. Oregon Health & Science University and ... partner institutions across the Northwest, have received federal funding ... emerging or re-emerging infectious diseases that pose a serious ... the collaborative Pacific Northwest Regional Center for Excellence (PNWRCE) ...
... LLC has incorporated the NexCura(R) Cancer ProfilerTools from Thomson ... portal that provides information tools and clinically useful content ... their patients."This collaboration is another important step in helping ... Chris Yoo, Ph.D., president and CEO of MedTrust Online. ...
... Nichols Institute Diagnostics, Pleads Guilty to Felony Misbranding ... its subsidiary, Nichols Institute Diagnostics (NID), have entered ... to resolve criminal and civil claims concerning various ... marketed and sold to laboratories throughout the country ...
... April 15 TopBestPennyStocks.com is pleased to ... are interested in stocks on the move and in the news ... http://www.TopBestPennyStocks.com Today,s focused alerts include: ChinaCast Education (Nasdaq: ... VM ), Netflix Inc. (Nasdaq: NFLX ), Pfizer Inc. ...
... in minimally invasive surgical techniques -- most notably, ... common surgical option across the United States for ... , A newer, third option is a hybrid ... safe and effective and compares favorably with standard ...
Cached Medicine News:Health News:Compirion and Henrico Doctors Hospital Team Up to Improve Quality of Care 2Health News:Compirion and Henrico Doctors Hospital Team Up to Improve Quality of Care 3Health News:Compirion and Henrico Doctors Hospital Team Up to Improve Quality of Care 4Health News:Compirion and Henrico Doctors Hospital Team Up to Improve Quality of Care 5Health News:OHSU scientists partner with others to form center aimed at combating infectious diseases 2Health News:OHSU scientists partner with others to form center aimed at combating infectious diseases 3Health News:MedTrust Online to Provide NexCura Cancer Profiler Tools from Thomson Reuters to Oncologists 2Health News:Quest Diagnostics to Pay U.S. $302 Million to Resolve Allegations That a Subsidiary Sold Misbranded Test Kits 2Health News:Quest Diagnostics to Pay U.S. $302 Million to Resolve Allegations That a Subsidiary Sold Misbranded Test Kits 3Health News:Quest Diagnostics to Pay U.S. $302 Million to Resolve Allegations That a Subsidiary Sold Misbranded Test Kits 4Health News:TopBestPennyStocks.com Issues Technical Trade Alerts on Hot Stocks in the Market Today: CAST, VM, NFLX, PFE, AA, & COF 2Health News:Helping hand of hybrid surgery benefits colorectal patients 2
The reliable and easy-to-use 3900/P pulse oximeter is now more advanced - featuring TruTrak+ technology, the proprietary clinical motion algorithm from Datex+-Ohmeda....
... Digital Pulse Oximeter monitors SpO2, ... It is designed to provide ... patients. The device rejects spontaneous ... the operator of excess artifacts ...
... The 8600FO is designed to ... MRI users for patient safety ... Fiber Optic Sensors and Cables ... is eliminated, as well as ...
... The 8600 Series Tabletop/Portable ... simple universal tool for patient ... continuous monitoring, the 8600 has ... professionals worldwide and is recognized ...
Medicine Products: